![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, July 23, 2004 9:35:34 AM
http://www.nus.edu.sg/nex/instructors.htm#shahi
Dr Gurinder Shahi
Dr. Gurinder Shahi is CEO of BioEnterprise Asia. He is currently a Visiting Scholar/Executive-in-Residence at the University of Southern California's Marshall School of Business. He received his MBBS and PhD from the National University of Singapore, and went on to obtain his MPH in international health policy and management from Harvard University. Gurinder is a leading expert on change leadership and management. He has worked with leading international organization and corporations including the Rockefeller Foundation and the United Nations Development Programme. Among other initiatives, he was closely involved with the effort to establish the International Vaccine Institute and the Asia-Pacific International Molecular Biology Network. He also played a key role in helping to establish Lynk Biotechnologies, one of Singapore's leading biotech companies. Dr. Shahi served as lead editor for "International Perspectives on Environment, Development and Health: Toward a Sustainable World" (Springer Publishing, New York, 1997). He recently wrote the highly acclaimed book, "BioBusiness in Asia : How Asia Can Capitalize on the Life Science Revolution" (Pearson Prentice Hall, 2004).
http://www.marshall.usc.edu/web/IBEARMBA.cfm?doc_id=6415
IBEAR hosted world-renowned bioscience expert Dr. Gurinder Shahi for 6 intense seminars April 7, 8 and 9th, 2004. Drawing a diverse audience of medical professionals from USC Keck School of Medicine; faculty, students and staff from the California Institute of Technology, graduate students in business, medicine and life sciences; plus seasoned bioscience industry executives, Dr. Shahi presented an overview of the exponential growth expected in the bioscience industry over the coming years.
Dr. Shahi’s latest book, "BioBusiness in Asia - How Asia Can Capitalize on the Life Science Revolution" is published by Prentice Hall [ISBN #0130620459].
Reviews of the book:
"A brilliant, candid, readable book - a well-organized and comprehensive tour d'horizon of biotechnology's possibilities in Asia. Through this meticulous effort, Gurinder Shahi emerges as both a scientific and economic seer of highest regard."
Carl Feldbaum, President, Biotechnology Industry Organization
"An astonishingly insightful and valuable book that comprehends the science, business and public policy issues that confront Asia as life science begins to drive national and regional economies. A must read for serious business, political and policy leaders in the region and internationally."
David Beier, former Life Science Policy Advisor to US President Clinton and Vice-President Gore
"Breathtaking! One-stop shopping for Asia (and global) "BioBusiness" insight and analysis – both broad and deep. A superb contribution to everyone, whether new to the topic or experienced, who is interested in Asia’s BioBusiness opportunities. A tour d’force!"
Prof Jack G. Lewis, Marshall School of Business, University of Southern California
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM